ConductScience.org, home

Paper38017184

An optimization framework to guide the choice of thresholds for risk-based cancer screening.

Brentnall AR and 7 others. NPJ Digit Med, 2023. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. An optimization framework to guide the choice of thresholds for risk-based cancer screening. Papers, record 38017184. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38017184

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An optimization framework to guide the choice of thresholds for risk-based cancer screening.
PubMed
Journal
NPJ Digit Med
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2025-05-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brentnall ARAdam Rhttps://orcid.org/0000-0001-6327-4357
2Atakpa ECEmma C
3Hill HHarryhttps://orcid.org/0000-0002-0908-5595
4Santeramo RRuggierohttps://orcid.org/0000-0001-7107-235X
5Damiani CCelestehttps://orcid.org/0000-0002-1990-6684
6Cuzick JJack
7Montana GGiovannihttps://orcid.org/0000-0003-3942-3900
8Duffy SWStephen W

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
28396Cancer Research UKUnited KingdomPubMed
28689Cancer Research UKUnited KingdomPubMed
2019DecPR1395Breast Cancer NowUnited KingdomPubMed

Source PubMed

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135110696The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation.Br J Cancer2022https://conductscience.org/library/papers/35110696PubMed
231848103Risk-based breast cancer screening strategies in women.Best Pract Res Clin Obstet Gynaecol2020https://conductscience.org/library/papers/31848103PubMed
39864771[Detection of cancer, sensitivity of the test and sensitivity of the screening program].Rev Epidemiol Sante Publique1998https://conductscience.org/library/papers/9864771PubMed
417377838An overview of prognostic factors for long-term survivors of breast cancer.Breast Cancer Res Treat2008https://conductscience.org/library/papers/17377838PubMed
532226220Risk Models for Breast Cancer and Their Validation.Stat Sci2020https://conductscience.org/library/papers/32226220PubMed
634051753Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?BMC Cancer2021https://conductscience.org/library/papers/34051753PubMed
729736008Psychological impact of providing women with personalised 10-year breast cancer risk estimates.Br J Cancer2018https://conductscience.org/library/papers/29736008PubMed
819884547Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening.J Clin Oncol2009https://conductscience.org/library/papers/19884547PubMed
933844853Cost-effectiveness of risk-based breast cancer screening: A systematic review.Int J Cancer2021https://conductscience.org/library/papers/33844853PubMed
1033504648Toward robust mammography-based models for breast cancer risk.Sci Transl Med2021https://conductscience.org/library/papers/33504648PubMed
1137278627Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study.Radiology2023https://conductscience.org/library/papers/37278627PubMed
1217717337NICE's cost effectiveness threshold.BMJ2007https://conductscience.org/library/papers/17717337PubMed
1334767469Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model.J Clin Oncol2022https://conductscience.org/library/papers/34767469PubMed
1434575693Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?J Pers Med2021https://conductscience.org/library/papers/34575693PubMed
1533937853OPTIMAM Mammography Image Database: A Large-Scale Resource of Mammography Images and Clinical Data.Radiol Artif Intell2021https://conductscience.org/library/papers/33937853PubMed
1637310244Evaluation of an AI Model to Assess Future Breast Cancer Risk.Radiology2023https://conductscience.org/library/papers/37310244PubMed
1710943268The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up.Radiol Clin North Am2000https://conductscience.org/library/papers/10943268PubMed
1829978189Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.JAMA Oncol2018https://conductscience.org/library/papers/29978189PubMed
1937104728Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer.J Clin Oncol2023https://conductscience.org/library/papers/37104728PubMed
2035027757Optimizing risk-based breast cancer screening policies with reinforcement learning.Nat Med2022https://conductscience.org/library/papers/35027757PubMed

See all 25 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42149286Artificial intelligence for risk-stratified breast cancer screening: a systematic review of evidence, clinical integration, and ethical implications in risk assessment tools.Radiol Med2026https://conductscience.org/library/papers/42149286PubMed
42069897Economic evaluation of artificial intelligence for cancer detection in the UK breast screening programme.Br J Cancer2026https://conductscience.org/library/papers/42069897PubMed
41881847Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study.Cancer Discov2026https://conductscience.org/library/papers/41881847PubMed
41623885Federated multimodal AI for precision-equitable diabetes care.Front Digit Health2025https://conductscience.org/library/papers/41623885PubMed
40940998Artificial Intelligence-Driven Personalization in Breast Cancer Screening: From Population Models to Individualized Protocols.Cancers (Basel)2025https://conductscience.org/library/papers/40940998PubMed
39235813Cost-Effectiveness of AI for Risk-Stratified Breast Cancer Screening.JAMA Netw Open2024https://conductscience.org/library/papers/39235813PubMed
38326868Are better AI algorithms for breast cancer detection also better at predicting risk? A paired case-control study.Breast Cancer Res2024https://conductscience.org/library/papers/38326868PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38017184

GET https://conductscience.org/api/papers/v1/38017184/references?page=2